Airway epitheliol cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection

Immunobiology

Volumn 201, Issue 1, 1999, Pages 88-106

  Becker, Susanne ^a,b   Soukup, Joleen M ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b EPA Human Studies Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA CHEMOKINE; EOTAXIN; RANTES;

ARTICLE; BRONCHIOLITIS; CELL ACTIVATION; CHEMOTAXIS; COCULTURE; DISEASE COURSE; EOSINOPHIL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MALE; MONOCYTE; MONONUCLEAR CELL; NEUTROPHIL; NORMAL HUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CYTOLOGY; IMMUNOLOGY; LUNG; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; VIROLOGY;

CELL LINE; CHEMOKINES, CC; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; HUMANS; LUNG; MALE; MONOCYTES; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TUMOR CELLS, CULTURED;

EID: 0032590196     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(99)80049-7     Document Type: Article

References (52)

1. CARLSEN, K. H., and I. ORSTAVIK. 1984. Bronchopulmonary obstruction in children with respiratory virus infections. Eur. J. Respir. Dis. 65: 92.
2. HEMMING, V. G., G. A. PRINCE, J. R. GROOTHUIS, and G. R. SIBER. 1995. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin. Microbiol. Rev. 8: 22.
3. ENGLUND, J. A., P. A. PIEDRA, A. JEWELL, K. PATEL, B. B. BAXTER, and E. WHIMBEY. 1995. Rapid diagnosis of respiratory syncytial virus infection sin immunocompromised adults. J. Clin. Microbiol. 1996.
4. DOWELL, S. F., L. J. ANDERSON, H. E. GARY, JR., D. D. ERDMAN, J. F. PLOUFFE, T. M. FILE, JR., B. J. MARSTON, and R. F. BREIMAN. 1996. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J. Inf. Dis. 174: 456.
5. NEILSON, K. A., and E. J. JUNIS. 1990. Demonstration of respiratory syncytial virus in an autopsy series. Pediat. Pathol. 10: 491.
6. LUGO, R. A., and M. C. NAHATA. 1993. Pathogenesis and treatment of bronchiolitis. Clin. Pharmacy 12: 95.
7. WELLIVER, R. C., M. SUN, D. RINALDO, and P. L. OGRA. 1986. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J. Pediatr. 109: 776.
8. WELLIVER, R. C., T. N. KAUL, M. SUN, and P. L. OGRA. 1984. Defective regulation of immune responses in respiratory syncytial virus infection. Journal of Immunology 133: 1925.
9. ANDERSON, L. J., and C. A. HEILMAN. 1995. Protective and disease-enhancing immune responses to respiratory syncytial virus. J. Inf. Dis. 171: 1.
10. KAPIKAIN, A. Z., R. H. MITCHELL, R. M. CHANOCK, R. A. SHVEDOFF, and C. E. STEWART. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89: 405-421.
11. OPENSHAW, P. J., S. L. CLARKE, and F. M. RECORD. 1992. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4: 493.
12. OPENSHAW, P. J. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Sem. Immunopathol. 17: 187.
13. GRAHAM, B. S., L. A. BUNTON, P. F. WRIGHT, and D. T. KARZON. 1991. Role of T lymphocytes subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Invest. 88: 1026.
14. SOZZANI, S., M. LOCATI, D. ZHOU, M. RIEPPI, W. LUINI, G. LAMORTE, G. BIANCHI, N. POLENTARUTTI, P. ALLAVENA, and A. MANTOVANI. 1995. Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines. J. Leukoc. Biol. 57: 788.
15. TAUB, D. D., and J. J. OPPENHEIM. 1994. Chemokines, inflammation and the immune system. Therap. Immunol. 1: 229.
16. MATSUSHIMA, K., K. MORISHITA, T. YOSHIMURA, S. LAVU, Y. KOBAYASHI, W. LEW, E. APPELLA, H. F. KUNG, E. J. LEOPARD, and J. J. OPPENHEIM. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167: 1883.
17. LUINI, W., S. SOZZANI, J. VAN DAMME, and A. MANTOVANI. 1994. Species-specificity of monocyte chemotactic protein-1 and -3. Cytokine 6: 28.
18. STELLATO, C., P. COLLINS, P. D. PONATH, D. SOLER, W. NEWMAN, G. LA ROSA, H. LI, J. WHITE, L. M. SCHWIEBERT, D. BICKEL, M. LIU, B. S. BOCHNER, T. WILLIAMS, and R. P. SCHLEIMER. 1997. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J. Clin. Invest. 99: 926.
19. SCHALL, T. J., K. BACON, K. J. TOY, and D. V. GOEDDEL. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669.
20. SCHWEIZER, R. C., B. A. WELMERS, J. A. RAAIJMAKERS, P. ZANEN, J. W. LAMMERS, and L. KOENDERMAN. 1994. RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83: 3697.
21. PONATH, P. D., S. QIN, D. J. DOUGLAS, I. CLARK-LEWIS, J. WANG, N. KASSAM, H. SMITH, X. SHI, J.-A. CONZALO, W. NEWMAN, J.-C. GUTIERREZ-RAMOS, C. R. MACKAY. 1996. Cloning of human eosinophil chemoattractant, eotaxin: expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97: 604.
22. YAMADA, H., K. HIRAI, M. MIYAMASU, M. IKURA, Y. MISAKI, S. SHOJI, T. TAKAISHI, T. KASAHARA, Y. MORITA, and K. ITO. 1997. Eotaxin is a potent chemotaxin for basophils. Biochem. Biophys. Res. Comm. 231: 365.
23. BECKER, S., H. S. KOREN, and D. C. HENKE. 1993. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and dytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am. J. Respir. Cell Mol. Biol. 8: 20.
24. NOAH, T. L., and S. BECKER. 1993. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 265: L472.
25. FIEDLER, M. A., K. WERNKE-DOLLRIES, and J. M. STARK. 1995. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269: L865.
26. MASTRONARDE, J. G., B. HE, M. M. MONICK, N. MUKAIDA, K. MATSUSHIMA, and G. W. HUNNINGHAKE. 1995. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J. Inf. Dis. 174: 262.
27. OLSEZEWSKA-PAZDRAK, B., A. CASOLA, T. SAITO, R. ALAM, S. E. CROWE, F. MEI, P. L. OGRA, and GAROFALO, R. P. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72: 4756.
28. BECKER, S., W. REED, F. W. HENDERSON, and T. L. NOAH. 1997. RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. Am. J. Physiol. 272: L512.
29. NOAH, T. L., F. W. HENDERSON, I. A. WORTMAN, R. B. DEVLIN, J. HANDY, H. S. KOREN, and S. BECKER. 1995. Nasal cytokine production inviral acute upper respiratory infection of childhood. J. Inf. Dis. 171: 584.
30. ARNOLD, R., G. KONIG, H. GALATTI, H. WERCHAU, and W. KONIG. 1995. Cytokine (IL-8, IL-6, TNF) and soluble TNF receptor I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection. Immunology 85: 364.
31. KONIG, B., T. KRUST, H. J. STRECKERT, and W. KONIG. 1996. IL-8 release from human neutrophils by respiratory syncytial virus is independent of viral replication. J. leukocyte Biol. 60: 253.
32. TREUHAFT, M. W., and M. O. BEEM. 1982. Defective interfering particles of respiratory syncytial virus. Inf. Immun. 37: 439.
33. REDDEL, R. R., Y. KE, B. L. GERWIN, M. G. MCMENAMIN, J. LECHNER, T. R. SU, D. E. BRASH, J. B. PARK, J. S. RHIM, and C. C. HARRIS. 1988. Transformation of human bronchial epithelial cells with SV40 or adenovirus-12 SV40 hybrid virus or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48: 1904.
34. KOREN, H. S., R. B. DEVLIN, D. E. GRAHAM, R. MANN, M. P. MCGHEE, D. H. HORSTMAN, W. J. KOZUMBO, S. BECKER, D. E. HOUSE, W. F. MCDONNELL, and P. A. BROMBERG. 1989. Ozone induced inflammation in the lower airways of human subjects. Am. J. Respir. Dis. 139: 407.
35. YING, S., Q. MENG, L. TABORDA-BARATA, C. J. CORRIGAN, J. BARKANS, B. ASSOUFI, R. MOQBEL, S. R. DURHAM, A. B. KAY. 1996. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur. J. Immunol. 26: 70-76.
36. IZUMI, S., K. HIRAI, M. MIYAMASU, Y. TAKAHASHI, Y. MISAKI, T. TAKAISHI, Y. MORITA, K. MATSUSHIMA, N. IDA, H. NAKAMURA, T. KASAHARA, K. ITO. 1997. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. Eur. J. Immunol. 27: 816.
37. MIYAMASU, M., K. HIRAI, H. TAKAHASHI, M. IIDA, M. YAMAGUCHI, T. KOSHINO, T. TAKAISHI, Y. MORITA, K. OHTA, T. KASAHARA, et al. 1995. Chemotactic agonists induce cytokine generation in eosinophils. J. Immunol. 154 1339.
38. BAGGIOLINI, M., P. LOETSCHER, B. MOSER. 1995. Interleukin-8 and the chemokine family. Int. J. Immunopharm. 17: 103.
39. LUKACS, N. W. 1996. Cytokines in allergic eosinophilic airway inflammation. Biol. Signals 5: 209.
40. ALAM, R., J. YORK, M. BOYARS, S. STAFFORD, J. A. GRANT, J. LEE, P. FORSYTHE, T. SIM, and N. IDA. 1996. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153: 1398.
41. WEBB, M. S., R. L. HENRY, A. D. MILNER, G. M. STOKES, and A. S. SWARBRICK. 1985. Continuing respiratory problems three and a half years after acute viral bronchiolitis. Arch. Dis. Childhood 60: 1064.
42. OLSZEWSKA-PAZDRAK, B., A. CASOLA, T. SAITO, R. ALAM, S. E. CROWE, F. MEI, P. L. OGRA, and R. P. GAROFALO 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72: 4756.
43. TAUB, D. D., and J. J. OPPENHEIM. 1994. Chemokines, inflammation and the immune system. Therap. Immunol. 1: 229.
44. KIMATA, H., A. YOSHIDA, C. ISHIOKA, M. FUJIMOTO, I. LINDLEY, and K. FURUSHO. 1996. RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J. Exp. Med. 183: 2397.
45. PETERSEN, L., J. K. BRASSO, M. PRYDS, and P. S. SKOV. 1996. Histamine release in intact human skin by monocytes chemoattractant factor-1, RANTES, macrophage inflammatory protein-1 alpha, stem cell factor, anti-IgE, and codeine as determined by an ex vivo skin microdialysis technique. J. Aller. Clin. Immunol. 98: 790.
46. KUNA, P., S. R. REDDIGARI, T. J. SCHALL, D. RUCINSKI, M. Y. VIKSMAN, and A. P. KAPLAN. 1992. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J. Immunol. 149: 636-642.
47. WELLIVER, R. C., and P. L. OGRA. 1987. Respiratory syncytial virus specific IgE antibody responses at the mucosal surface: predictive value for recurrent wheezing and suppression by ribavirin therapy. Adv. Exp. Med. Biol. 216B: 1701.
48. GAROFALO, R., J. L. KIMPEN, R. C. WELLIVER, and P. L. OGRA. 1992. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediat. 120: 28.
49. SKONER, D. P., P. FIREMAN, L. CALIGUIRI, and H. DAVIS. 1992. Plasma elevations of histamine and a prostaglandin metabolite in acute bronchiolitis. Am. Rev. Respi. Dis. 142: 359.
50. BECKER, S., J. QUAY, and J. SOUKUP. 1991. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147: 4307.
51. MARTIN, T., P. M. CARDARELLI, G. C. PARRY, K. A. FELTS, and R. R. COBBS. 1997. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Europ. J. Immunol. 27: 1091.
52. BECKER, S., J. QUAY, H. S. KOREN, and J. S. HASKILL. 1994. Constitutive and stimulated MCP-1 and GRO expression in human airway epithelium and bronchoalveolar macrophages. Am. J. Physiol. 266: L278.